Robotic Lung Resection for Non-Small Cell Lung Cancer

被引:23
|
作者
Wei, Benjamin [1 ]
Eldaif, Shady M. [2 ]
Cerfolio, Robert J. [1 ]
机构
[1] Univ Alabama Birmingham, Med Ctr, Div Cardiothorac Surg, 703 19th St South,ZRB 739, Birmingham, AL 35294 USA
[2] Northside Hosp Canc Inst, Thorac Surg Sect, 960 Johnson Ferry Rd,Suite 100, Atlanta, GA 30342 USA
关键词
Robotic; Robot-assisted; Lobectomy; Lung cancer; ASSISTED THORACIC-SURGERY; SURGICAL LOBECTOMY; NATIONAL DATABASE; EXPERIENCE; MORBIDITY;
D O I
10.1016/j.soc.2016.02.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Robotic-assisted pulmonary lobectomy can be considered for patients able to tolerate conventional lobectomy. Contraindications to resection via thoracotomy apply to patients undergoing robotic lobectomy. Team training, familiarity with equipment, troubleshooting, and preparation are critical for successful robotic lobectomy. Robotic lobectomy is associated with decreased rates of blood loss, blood transfusion, air leak, chest tube duration, length of stay, and mortality compared with thoracotomy. Robotic lobectomy offers many of the same benefits in perioperative morbidity and mortality, and additional advantages in optics, dexterity, and surgeon ergonomics as video-assisted thoracic lobectomy. Longterm oncologic efficacy and cost implications remain areas of study.
引用
收藏
页码:515 / +
页数:19
相关论文
共 50 条
  • [31] Non-small cell lung cancer
    Adamietz, I. A.
    Niederle, N.
    ONKOLOGE, 2010, 16 (06): : 63 - 74
  • [32] Surgical Resection in Combination With Lung Volume Reduction Surgery for Stage I Non-Small Cell Lung Cancer
    Yacoub, Wael N.
    Meyers, Bryan F.
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2010, 22 (01) : 38 - 43
  • [33] Lactate dehydrodgenase levels predict pulmonary morbidity after lung resection for non-small cell lung cancer
    Turna, A
    Solak, M
    Çetinkaya, E
    Kiliçgün, A
    Metin, M
    Sayar, A
    Gürses, A
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2004, 26 (03) : 483 - 487
  • [34] Lobar or sublobar resection of peripheral stage I non-small cell lung cancer
    Lima, Pedro Guimaraes Rocha
    Glorion, Matthieu
    Liberman, Moishe
    CURRENT OPINION IN PULMONARY MEDICINE, 2024, 30 (04) : 352 - 358
  • [35] The value of completion residual lung resection in ipsilateral recurrent non-small cell lung cancer
    Yang, Yong
    Wang, Yichao
    Wan, Ziwei
    Qin, Xiong
    Zhu, Yuming
    Sheng, Bingyong
    Zhao, Xiaogang
    FRONTIERS IN SURGERY, 2022, 9
  • [36] Diagnosis and treatment of lung cancer - Non-small cell lung cancer, small cell lung cancer and carcinoids
    End A.
    European Surgery, 2006, 38 (1) : 45 - 53
  • [37] Therapeutic advances in non-small cell lung cancer
    Vallieres, Eric
    Peters, Solange
    Van Houtte, Paul
    Dalal, Paras
    Lim, Eric
    THORAX, 2012, 67 (12) : 1097 - 1101
  • [38] Oncological Outcomes of Robotic Lobectomy and Radical Lymphadenectomy for Early-Stage Non-Small Cell Lung Cancer
    Gallina, Filippo Tommaso
    Taje, Riccardo
    Forcella, Daniele
    Corzani, Felicita
    Cerasoli, Virna
    Visca, Paolo
    Coccia, Cecilia
    Pierconti, Federico
    Sperduti, Isabella
    Cecere, Fabiana Letizia
    Cappuzzo, Federico
    Melis, Enrico
    Facciolo, Francesco
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (08)
  • [39] Robotic Surgery for Non-Small Cell Lung Cancer Treatment in High-Risk Patients
    Zirafa, Carmelina Cristina
    Romano, Gaetano
    Sicolo, Elisa
    Cariello, Claudia
    Morganti, Riccardo
    Conoscenti, Lucia
    Hung-Key, Teresa
    Davini, Federico
    Melfi, Franca
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)
  • [40] 500 Consecutive Robotic Lobectomies for Non-Small Cell Lung Cancer: Perioperative and Oncologic Outcomes
    Herrera, Luis J.
    Wherley, Eric M.
    Agyabeng-Dadzie, Kojo
    Ramsuchit, Bhupaul
    Johnston, Matthew A.
    Escalon, Juan C.
    INNOVATIONS-TECHNOLOGY AND TECHNIQUES IN CARDIOTHORACIC AND VASCULAR SURGERY, 2021, 16 (05) : 441 - 447